Platelet-Activating Factor Blockade Inhibits the T-Helper Type 17 Cell Pathway and Suppresses Psoriasis-Like Skin Disease in K5.hTGF-β1 Transgenic Mice-Reference-Cited by-同舟云学术

Platelet-Activating Factor Blockade Inhibits the T-Helper Type 17 Cell Pathway and Suppresses Psoriasis-Like Skin Disease in K5.hTGF-β1 Transgenic Mice

Published:2011-02 Issue:2 Volume:178 Page:699-708
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Singh Tej Pratap,Huettner Barbara,Koefeler Harald,Mayer Gerlinde,Bambach Isabella,Wallbrecht Katrin,Schön Michael P.,Wolf Peter

Funder

Oesterreichische Nationalbank

Medizinische Universität Graz

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference65 articles.

1. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice;Ishii;Prog Lipid Res,2000

2. Structural identification of platelet activating factor in psoriatic scale;Mallet;Biochem Biophys Res Commun,1985

3. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression;Walterscheid;J Exp Med,2002

4. Inflammation and melanoma growth and metastasis: the role of platelet-activating factor (PAF) and its receptor;Melnikova;Cancer Metastasis Rev,2007

5. Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis;Pei;J Immunol,1998

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PLATELET ACTIVATION IN THE PROGNOSIS OF CARDIOVASCULAR RISKS IN PATIENTS WITH PSORIASIS;Problems of Biological, Medical and Pharmaceutical Chemistry;2024-09-01

2. LPCAT1 Facilitates Keratinocyte Hyperproliferation and Skin Inflammation in Psoriasis by Regulating GLUT3;Journal of Investigative Dermatology;2024-07

3. Relationship between Th17 cell proportion and IL-17/-18 levels and disease progression in patients with multiple myeloma;Molecular & Cellular Toxicology;2023-12-12

4. Lysophospholipase D from Thermocrispum limits psoriatic inflammation by hydrolyzing epidermal lysoplasmalogen produced by group IIF secreted phospholipase A2;Biochimie;2023-12

5. Platelet activation: a promoter for psoriasis and its comorbidity, cardiovascular disease;Frontiers in Immunology;2023-08-15